Atlas Trials

An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence

Clinical trial NCT00847535 · COMPLETED

Trial details

NCT number
NCT00847535
Sponsor
Cook MyoSite
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stress Urinary IncontinenceCell Therapy
Start date
2008-10-09
Primary completion
2011-11-02
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.